This is a preprint.
From Byte to Bench to Bedside: Molecular Dynamics Simulations and Drug Discovery
- PMID: 38076508
- PMCID: PMC10705576
From Byte to Bench to Bedside: Molecular Dynamics Simulations and Drug Discovery
Update in
-
From byte to bench to bedside: molecular dynamics simulations and drug discovery.BMC Biol. 2023 Dec 29;21(1):299. doi: 10.1186/s12915-023-01791-z. BMC Biol. 2023. PMID: 38155355 Free PMC article.
Abstract
Molecular dynamics (MD) simulations and computer-aided drug design (CADD) have advanced substantially over the past two decades, thanks to continuous computer hardware and software improvements. Given these advancements, MD simulations are poised to become even more powerful tools for investigating the dynamic interactions between potential small-molecule drugs and their target proteins, with significant implications for pharmacological research.
Conflict of interest statement
Competing interests The authors declare that they have no competing interests.
References
-
- Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol. 2002;9(9):646–52. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous